Merck Life Science, a division of Merck KGaA, partnes with researchers and manufacturers to enable scientific breakthroughs. We provide innovative bioprocess, lab, and analytical solutions, enabling efficient workflows, reliable quality, and accelerated timelines. Our portfolio spans cell culture, chromatography, lab essentials, and digital tools, backed by global support.
Merck Life Science partners with other companies to accelerate their success. We pursue co-creation, reliability, and measurable value across the lifecycle. We align objectives and quality, ensure supply continuity, and provide integrated materials, instruments, services, and data. We enable compliant, auditable processes and AI-enabled insights to drive growth, and resilience.
Albert Portoles
Scientific and Technological Centers of the Universitat de Barcelona (CCiTUB)
CCiTUB (Centres Científics i Tecnològics de la Universitat de Barcelona) is one of the largest mid-sized scientific and technical infrastructures in Spain, located at the Campus Diagonal of the University of Barcelona — the leading biotechnology hub in southern Europe.
With highly qualified technical staff and the widest variety of instrumental technologies in the country, CCiTUB offers specialised services to companies in the HealthTech sector with international quality standards, including ISO 9001:2015 certification.
Our key capabilities include:
Biomolecular Analysis: advanced proteomics, metabolomics, and small molecule ADME/PK studies
Pharmaceutical Characterisation: ultra-high-field NMR (1.0 GHz, unique in Spain) for biologics, antibodies, and nucleic acid fragments
Cell Analysis: multiparametric flow cytometry, immunophenotyping, and cell sorting for advanced therapies
Mass Spectrometry: hybrid Orbitrap IQ-X and QTRAP 7500 for metabolite identification, quality control, and biodistribution studies
Imaging: MALDI-Imaging, cryo-FIBSEM, and correlative microscopy for neurodegenerative disease research
CCiTUB serves pharma, biotech, diagnostics, medical devices, cosmetics, and nutraceutical sectors, providing immediate access to cutting-edge technologies without capital investment, backed by a network of over 100 health sector organisations and 2,700 professionals at the Barcelona Science Park.
CCiTUB seeks to connect with HealthTech companies looking for a reliable analytical partner to support their R&D and quality control needs. We are open to:
- Service agreements with pharma, biotech, diagnostics and medical device companies requiring advanced analytical capabilities
- Instrument evaluation partnerships with equipment manufacturers interested in testing and validating new instruments or applications, leveraging our expert technical team and broad network of over 2,700 researchers and professionals
- Public-private consortia for European and national research funding programmes (Horizon Europe, CDTI, etc.)
Werfen is a growing, family-owned, and innovative company founded in 1966 in Barcelona, Spain. We operate directly in nearly 30 countries and in more than 100 territories through distributors, with headquarters and Technology Centers located in Europe and the United States. The Immunoassay Technology Center in Barcelona has consolidated experience in the research, development, and manufacturing of IVD immunoassays and biomaterials.
Innovation is one of Werfen’s fundamental pillars, and we innovate at all levels, from diagnostic targets, biomaterials and reagents, protein production processes and assay technologies. We strive to strengthen our immunoassay know-how and technological capabilities with the ultimate goal of increasing efficiency and robustness, reducing time-to-market, and streamlining operations.
Werfen open innovation strategy is based on engagement with biotech companies and research institutions. We seek co-development or in-licensing opportunities.
Marina Bruch
Scientist
Partnership Goal
Werfen open innovation strategy is based on engagement with biotech companies and research institutions. We seek co-development or in-licensing opportunities.
